W. C. Low
Publications While At Healthpartners
Comparative effectiveness of intracerebroventricular, intrathecal, and intranasal routes of AAV9 vector administration for genetic therapy of neurologic disease in murine mucopolysaccharidosis type I
Frontiers in Molecular Neuroscience.
Intranasal adeno-associated virus mediated gene delivery and expression of human iduronidase in the central nervous system: a noninvasive and effective approach for prevention of neurologic disease in mucopolysaccharidosis Type I
Human Gene Therapy.
Lysosomal enzyme can bypass the blood-brain barrier and reach the CNS following intranasal administration
Molecular Genetics and Metabolism.
Map of science